
Thomas Brown
Examiner (ID: 11072)
| Most Active Art Unit | 2601 |
| Art Unit(s) | 2786, 2899, 2742, 2787, 2306, 2601, 2604, 2305, 2857 |
| Total Applications | 1242 |
| Issued Applications | 1062 |
| Pending Applications | 29 |
| Abandoned Applications | 151 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14697573
[patent_doc_number] => 10376508
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-13
[patent_title] => Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
[patent_app_type] => utility
[patent_app_number] => 15/821193
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14471
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15821193
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/821193 | Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria | Nov 21, 2017 | Issued |
Array
(
[id] => 18043576
[patent_doc_number] => 11517508
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-06
[patent_title] => Composition for single-paste type hydraulic endodontic filling material comprising dimethyl sulfoxide
[patent_app_type] => utility
[patent_app_number] => 16/462927
[patent_app_country] => US
[patent_app_date] => 2017-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 3797
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16462927
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/462927 | Composition for single-paste type hydraulic endodontic filling material comprising dimethyl sulfoxide | Nov 20, 2017 | Issued |
Array
(
[id] => 13489907
[patent_doc_number] => 20180296496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => UNIFORM FILMS FOR RAPID-DISSOLVE DOSAGE FORM INCORPORATING ANTI-TACKING COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 15/818997
[patent_app_country] => US
[patent_app_date] => 2017-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17802
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15818997
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/818997 | UNIFORM FILMS FOR RAPID-DISSOLVE DOSAGE FORM INCORPORATING ANTI-TACKING COMPOSITIONS | Nov 20, 2017 | Abandoned |
Array
(
[id] => 12746032
[patent_doc_number] => 20180140511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => NANO-COMPLEXES FOR ENAMEL REMINERALIZATION
[patent_app_type] => utility
[patent_app_number] => 15/816936
[patent_app_country] => US
[patent_app_date] => 2017-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15816936
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/816936 | Nano-complexes for enamel remineralization | Nov 16, 2017 | Issued |
Array
(
[id] => 14273229
[patent_doc_number] => 20190133899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => INDIVIDUAL'S SENSITIVITY TO FLUORIDE POISONING
[patent_app_type] => utility
[patent_app_number] => 15/808104
[patent_app_country] => US
[patent_app_date] => 2017-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1596
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15808104
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/808104 | Individual's sensitivity to fluoride poisoning | Nov 8, 2017 | Issued |
Array
(
[id] => 15393881
[patent_doc_number] => 10537577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-21
[patent_title] => Compounds and compositions for ossification and methods related thereto
[patent_app_type] => utility
[patent_app_number] => 15/801964
[patent_app_country] => US
[patent_app_date] => 2017-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 26
[patent_no_of_words] => 13437
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15801964
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/801964 | Compounds and compositions for ossification and methods related thereto | Nov 1, 2017 | Issued |
Array
(
[id] => 15394053
[patent_doc_number] => 10537663
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-21
[patent_title] => Preparation method of hydrogel based on decellularized tissue using supercritical fluid-organic solvent system
[patent_app_type] => utility
[patent_app_number] => 15/800436
[patent_app_country] => US
[patent_app_date] => 2017-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 4036
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15800436
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/800436 | Preparation method of hydrogel based on decellularized tissue using supercritical fluid-organic solvent system | Oct 31, 2017 | Issued |
Array
(
[id] => 12641112
[patent_doc_number] => 20180105535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => Biologically Active Taxane Analogs and Methods of Treatment by Oral Administration
[patent_app_type] => utility
[patent_app_number] => 15/797145
[patent_app_country] => US
[patent_app_date] => 2017-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19744
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15797145
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/797145 | Biologically active taxane analogs and methods of treatment by oral administration | Oct 29, 2017 | Issued |
Array
(
[id] => 16518631
[patent_doc_number] => 10869833
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-22
[patent_title] => Drug delivery devices for delivery of ocular therapeutic agents
[patent_app_type] => utility
[patent_app_number] => 15/787600
[patent_app_country] => US
[patent_app_date] => 2017-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 96
[patent_figures_cnt] => 97
[patent_no_of_words] => 22576
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15787600
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/787600 | Drug delivery devices for delivery of ocular therapeutic agents | Oct 17, 2017 | Issued |
Array
(
[id] => 12231870
[patent_doc_number] => 20180064733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'USE OF BISPHOSPHONATES AS HIV/AIDS ADJUNCTIVE TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/783170
[patent_app_country] => US
[patent_app_date] => 2017-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16847
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15783170
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/783170 | USE OF BISPHOSPHONATES AS HIV/AIDS ADJUNCTIVE TREATMENT | Oct 12, 2017 | Abandoned |
Array
(
[id] => 16009441
[patent_doc_number] => 20200179563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => THREE-DIMENSIONAL (3-D) PRINTING INKS MADE FROM NATURAL EXTRACELLULAR MATRIX MOLECULES
[patent_app_type] => utility
[patent_app_number] => 16/341360
[patent_app_country] => US
[patent_app_date] => 2017-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341360
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/341360 | Three-dimensional (3-D) printing inks made from natural extracellular matrix molecules | Oct 11, 2017 | Issued |
Array
(
[id] => 16139301
[patent_doc_number] => 10702704
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Pain relief utilizing polymer based materials or a combination of LED bulbs, polymer based materials and a near field accelerator
[patent_app_type] => utility
[patent_app_number] => 15/729259
[patent_app_country] => US
[patent_app_date] => 2017-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 45
[patent_no_of_words] => 6691
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15729259
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/729259 | Pain relief utilizing polymer based materials or a combination of LED bulbs, polymer based materials and a near field accelerator | Oct 9, 2017 | Issued |
Array
(
[id] => 17097207
[patent_doc_number] => 20210284998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => Compositions for Transfecting Resistant Cell Types
[patent_app_type] => utility
[patent_app_number] => 16/334351
[patent_app_country] => US
[patent_app_date] => 2017-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11958
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16334351
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/334351 | Compositions for Transfecting Resistant Cell Types | Oct 1, 2017 | Abandoned |
Array
(
[id] => 12808912
[patent_doc_number] => 20180161474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => ABSORBENT ARTICLES COMPRISING GLYCERIDE COPOLYMERS
[patent_app_type] => utility
[patent_app_number] => 15/713762
[patent_app_country] => US
[patent_app_date] => 2017-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 385
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15713762
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/713762 | Absorbent articles comprising glyceride copolymers | Sep 24, 2017 | Issued |
Array
(
[id] => 14069589
[patent_doc_number] => 20190083682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => Method for coating catheters with a layer of antimicrobial agent
[patent_app_type] => utility
[patent_app_number] => 15/711424
[patent_app_country] => US
[patent_app_date] => 2017-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5592
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15711424
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/711424 | Method for coating catheters with a layer of antimicrobial agent | Sep 20, 2017 | Issued |
Array
(
[id] => 16998317
[patent_doc_number] => 11077099
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Oral tablet formulation of lenalidomide
[patent_app_type] => utility
[patent_app_number] => 16/341682
[patent_app_country] => US
[patent_app_date] => 2017-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 7752
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341682
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/341682 | Oral tablet formulation of lenalidomide | Sep 10, 2017 | Issued |
Array
(
[id] => 14243813
[patent_doc_number] => 10272089
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-30
[patent_title] => Methotrexate for proliferative vitreoretinopathy
[patent_app_type] => utility
[patent_app_number] => 15/699559
[patent_app_country] => US
[patent_app_date] => 2017-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6160
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15699559
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/699559 | Methotrexate for proliferative vitreoretinopathy | Sep 7, 2017 | Issued |
Array
(
[id] => 17080484
[patent_doc_number] => 20210275490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => METHODS OF TREATING TRIPLE-NEGATIVE BREAST CANCER USING COMPOSITIONS OF ANTIBODIES AND CARRIER PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/330359
[patent_app_country] => US
[patent_app_date] => 2017-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16330359
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/330359 | Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins | Sep 4, 2017 | Issued |
Array
(
[id] => 14711137
[patent_doc_number] => 20190246632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => NUCLEIC ACID-PEPTIDE CAPSULE COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 16/328946
[patent_app_country] => US
[patent_app_date] => 2017-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19737
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16328946
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/328946 | Nucleic acid-peptide capsule complexes | Aug 30, 2017 | Issued |
Array
(
[id] => 12676027
[patent_doc_number] => 20180117175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => TEMPLATED NANOCONJUGATES
[patent_app_type] => utility
[patent_app_number] => 15/691340
[patent_app_country] => US
[patent_app_date] => 2017-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15691340
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/691340 | TEMPLATED NANOCONJUGATES | Aug 29, 2017 | Abandoned |